piperidines and Stomatitis

piperidines has been researched along with Stomatitis* in 2 studies

Other Studies

2 other study(ies) available for piperidines and Stomatitis

Article	Year
Dose-limiting stomatitis associated with ibrutinib therapy: a case series. British journal of haematology, 2019, Volume: 185, Issue:4 Topics: Adenine; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; Pyrazoles; Pyrimidines; Stomatitis	2019
[Three cases of stomatitis caused by chemotherapy for gastrointestinal cancer that responded well to lafutidine]. Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:8 We described 3 cases of stomatitis caused by chemotherapy with the fluoropyrimidine preparation S-1, alone or combined with other anticancer drugs. The stomatitis did not respond to conventional oral mucosal treatment such as triamcinolone acetonide(Kenalog)or allopurinol, but improved after treatment with the histamine H2-receptor antagonist lafutidine. The concurrent use of lafutidine allowed these 3 patients to continue chemotherapy with no recurrence of stomatitis. We concluded that lafutidine may be a viable treatment option for chemotherapy-induced stomatitis, allowing treatment to be continued. Topics: Acetamides; Aged; Antineoplastic Combined Chemotherapy Protocols; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Piperidines; Pyridines; Stomatitis	2008

Article

Year

Dose-limiting stomatitis associated with ibrutinib therapy: a case series.

British journal of haematology, 2019, Volume: 185, Issue:4

Topics: Adenine; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; Pyrazoles; Pyrimidines; Stomatitis

2019

[Three cases of stomatitis caused by chemotherapy for gastrointestinal cancer that responded well to lafutidine].

Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:8

We described 3 cases of stomatitis caused by chemotherapy with the fluoropyrimidine preparation S-1, alone or combined with other anticancer drugs. The stomatitis did not respond to conventional oral mucosal treatment such as triamcinolone acetonide(Kenalog)or allopurinol, but improved after treatment with the histamine H2-receptor antagonist lafutidine. The concurrent use of lafutidine allowed these 3 patients to continue chemotherapy with no recurrence of stomatitis. We concluded that lafutidine may be a viable treatment option for chemotherapy-induced stomatitis, allowing treatment to be continued.

Topics: Acetamides; Aged; Antineoplastic Combined Chemotherapy Protocols; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Piperidines; Pyridines; Stomatitis

2008